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Chapter 1
Introduction
1.1 Clinical issue
Bone remodeling is a dynamic and continuous process required for the maintenance
of skeleton architecture which responds to mechanical stimuli [1]. The success of this
process means an equilibrium between bone resorption and formation [2, 3]. When
the equilibrium breaks, some pathologies arise. Moreover, this imbalance could be also
enhanced after the placement of an implant, due to the changes in the mechanical
conditions, which ends in aseptic loosening of the implant [4].
The absence of bone matrix production inside scaffolds is one of the main limitation
in the field of bone tissue engineering. Bone substitutes do not succeed in replying
the unique remodelling capacity of bone tissue yet. Thus, a deeper understanding of
the cellular behaviour is clearly necessary for the main types of bone cells [5]. A wider
comprehension of the events that occur between cell-environment interaction is crucial to
improve natural bone remodeling as well as bone regeneration after placing an implant.
Developing in vitro systems that create bone-like tissue has two main purposes that
fit here: understanding the mechanisms of bone formation to improve the bone graft
outcome and, more in general, replicating in vivo conditions to study specific disease or
potential therapies [6].
1.2 Anatomy and physiology
The process of bone remodelling is mainly conducted by two cell types: osteoclasts,
responsible for bone resorption; and osteoblasts, for bone formation. Osteoclasts are
1
Introduction 2
derived from hemopoietic precursors supplied by the bone marrow, whereas osteoblasts
are derived from mesenchymal stem cells in the bone marrow [7–9].
At the end of bone formation phase, osteoblasts can have one of four different fates:
become embedded in the bone as osteocytes, transform into inactive osteoblasts, undergo
a programmed cell-death (apoptosis) or become cells that deposit chondroid or chondroid
bone [10, 11].
Osteocytes are derived from obsteoblasts and make up over the 90% of the bone cells
[10–13]. However, the mechanism that control the differentiation of osteoblasts into
osteocytes embedded in bone matrix is not well understood. Despite that, the regulation
of the differentiation process seems to be critical for bone homeostasis [8, 12, 14].
These osteocytes act as mechanosensors that monitor and sense the mechanical environ-
ment within bone tissue by signalling to osteoclasts and osteoblasts to remodel. This
way, bone strength is maintained throughout life [9, 15, 16].
Osteoblasts-osteocytes transition (figure 1.1) depends on many variables: the mode of
ossification (intramembranous, perichondral, endochondral), the type of bone (woven or
lamellar bone), the location of bone formation, the species, and on the age and gender of
the individual. Franz-Odendaal et al. described the effect of each parameter mentioned
above [11].
Figure 1.1: Transitional cell types between preosteoblasts and osteocytes during os-
teoblast transformation in intramembranous ossification. 1: preosteoblast, 2: pre-
osteoblastic osteoblast, 3: osteoblast, 4: osteoblastic osteocyte (type I preosteocyte), 5:
osteoid-osteocyte (type II preosteocyte), 6: type III preosteocyte, 7: young osteocyte,
8: old osteocyte. Adapted from Tamara A. Franz-Odendaal et al 2006.
Osteoblasts morphology is altered from cuboid to dendritic shape during their differ-
entiation to osteocytes [17]. This transition is accompanied by a loss of cell volume,
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involving the reduction of organelle content. Moreover, there is an increase in the for-
mation and elongation of projections. The same way, connections with neighbouring
osteocytes within the bone extracellular matrix increase, as well as with osteoblasts on
the bone surface [13, 18, 19].
Apart from the morphological point of view, gene expression pattern also suffers from a
big change: expression of the osteoblasts marker enzyme alkaline phosphatase is reduced,
along with a reduction of type I collagen and bone sialoprotein 2 (BSP2), expression
of protein E11 is increased and dentin matrix protein 1 (DMP1) is induced with the
transformation [9, 20, 21]. Those parameters are detailed below and, some of them, will
be used along this work in order to distinguish cellular phenotype.
1.3 Background
In vitro cell mechanobiology studies have proved themselves to be a potential tool to
understand bone mechanobiology, which is crucial to the adaptive mechanism of bone.
In general, reliable in vitro models of bone tissue became a prerequisite tool for a wider
comprehension of the biological mechanisms taking place in bone tissue remodeling [22].
One of the most trending technique adapted from the past years to perform in vitro
studies is microfluidics. The microfluidics is a technique that allows to work with volumes
in small scale, typically submilimetric, where capillarity domains the mass transportation
[23, 24]. This reduction in dimensions involves saving chemical reagents, space and
wastes. Moreover, working in micro-scale systems allow greater control and versatility
in therms of pH and temperature [25].
Microfluidic-based devices are a good approach to evaluate the regulatory effects of single
mechano-chemical cues on cell behaviour. They also showed a flair for reproducing bone
tissue-like models by combining multiple stimuli and, hence, creating more in vivo-like
environment [26]. Furthermore, microfluidic platforms allow long-term culture of bone
cells over the 3D environment (essential for bone tissue culture) with a limited number
of cells and reagents per sample [13, 27].
Microfluidic devices allow to recreate physiological cellular microenvironments by includ-
ing biomimetic hydrogels and generating controlled chemical gradients. Here, hydrogels
made of collagen were selected because it is the major protein component of nature
bone, and it is the precursors matrix for direct bone repair [28]. This gels also favour
isolate factors for study, simulate laboratory analysis and modeling cellular, tissue and
organ level processes [22]. See in the figure 1.2 a picture of a simple microfluidic device
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which allows to put the cells through a chemical gradient in order to study the effects
of a growth factor [25].
Figure 1.2: (a): Microfluidic device where the cells are embedded in collagen hydrogels
inside the inner channel. (b): centre channel where cells live (pink color) and reservoir
channels where cells receive the culture medium (blue and green channels). Including
chemical or biological factors trough one of the reservoir channels triggers a diffusion
processes inside due to a chemical gradient inside the hydrogel. Adapted from Oihana
Moreno-Arotzarena et al, (2015).
As mentioned above, collagen hydrogels are widely used for in vitro experiments and
tissue engineering applications, becoming one of the best alternatives to substitute bi-
ological tissue in cell culture. Those hydrogels consist in a polymer network made of
connected filaments embedded on an aqueous medium [29, 30]. The final stiffness of the
hydrogel depends on both individual and global structure properties [31].
Dense fibrillar collagen matrices have been developed with the aim of replicating the
composition and the structure of actual osteoid tissue. Thanks to the composition,
texture and density, these matrices were proposed as connective tissue model for cell
culture [32]. The collagen hydrogel matrices provide an appropriate three dimensional
microenvironment for the adhesion, migration, proliferation and differentiation of os-
teoblast. Type I collagen is the major component of bone matrix and is widely used
in cell culture because is well known to induce the differentiation of mesenchymal cell
types [15, 33]. Summing up, cell cultured in type I collagen gels maintain their function
and ensure a 3D structure and the cell-cell interaction [14, 29, 34].
Researchers already cultured osteoblasts in type I collagen gel and they added supple-
ments to enhance the osteogenic behaviour: β-Glycerol phosphate and ascorbic acid
[12, 14, 35]. Here, a tridimensional culture is done by combining microfluidic devices
and collagen hydrogel. These 3D culture systems enhance osteoblastic and osteocytic
gene expression compared with cells cultured in 2D monolayer [12].
Some chemical assays are widely used in these in vitro experiments to discriminate
cell phenotype. As commented above, some biomolecules have been selected from the
literature as markers in osteogenic differentiation for this work [10, 11, 20, 36–39]. See
a resume of each cell type characteristics in figure 1.3:
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• Alkaline phosphatase (ALP): it is an enzyme that induces dephosphorylation of
organic compounds. ALP is produced by osteoblasts and it is released in cell
culture medium in the early stages of bone formation. ALP is widely recognized
as osteogenic marker for osteoblasts, whose concentration gets maximum values at
the beginning of the cell life and later, decreases when mineralization takes place
[39–41].
• Bone sialoprotein II (BSP2): it is present in bone and other mineralized tissues.
Bone cells produce this protein in early osteoblast differentiation stages. By mon-
itoring this protein, it is possible to study cell expression of mature osteoblast
phenotype [39].
• Dentin matrix production (DMP1): it is an extracellular matrix protein, critical
for proper mineralization of bone. In undifferentiated osteoblasts it is primarily a
nuclear protein that regulates the expression of osteoblast-specific genes. During
osteoblast maturation the protein becomes phosphorylated and is exported to the
extracellular matrix, where it orchestrates mineralized matrix formation [42]. By
monitoring this protein in the matrix, osteoblasts differentiation to osteocytes can
be studied.
Figure 1.3: Cellular events in bone remodeling: features of cell types according to
their maturation degree. Adapted from Gerald J. Atkins et al. (2011)
1.4 Objective
The final goal of this work was to perform an in vitro bone model inside microfluidic
devices in order to study osteoblasts behaviour. The different tasks aimed to study
osteogenic differentiation and bone matrix production of osteoblasts. The cell mark-
ers previously commented were quantified and cell connections and interactions were
tracked.
Understanding the regulatory mechanisms of osteoblast-osteocyte differentiation are of
significant for the development of bone forming reagents for the treatment of some
pathologies as osteoporosis, tissue engineering for regenerative medicine or to improve
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the osteointegration of prostheses. The obtained results might help to understand which
stimuli further improve bone regeneration and remodeling to apply, for instance, some
physical or biochemical conditions within the placement of a prosthesis.
Human osteoblasts (HOB) were seeded inside microfluidic devices and fed with Os-
teogenic Culture Medium (OCM) containing the supplements recommended in bibliogra-
phy [12]. HOB progressive differentiation and mineralization was followed by performing
different experiments along several timepoints.
Notice that the device shown in the figure 1.2 (b), has micropillars in the centre channel
which enclose the area. These posts retain the gel solution by hydrophobic surface
tension. In this work, similar microfluidic devices were used. However, the chamber was
composed of three channels instead of one. This difference is owing to the strength that
primary osteoblasts are able to do. If providing the collagen matrix with three channels,
the hydrogel finds more posts to bind to, so it is more difficult to detach. See in the
picture 1.4 a scheme of the geometry used.
Figure 1.4: Sketch of the inner geometry of the devices. 1: Gel ports. 2: Channel
ports. 3: Collagen gel channels. 4: Reservoir/medium channels. 5: Post of the hydrogel
channel where hydrogel grips.
Additionally to the three cell channels (figure 1.4-3), two media channels are in direct
contact to them (figure 1.4-4), through which OCM was provided to the cells. The
culture was incubated at 37◦C in a 5% CO2 atmosphere with replacement of medium
every 2-3 days.
In order to discriminate osteoblasts-osteocytes cell type, several markers from the litera-
ture were selected: the enzyme ALP, Calcium deposition and proteins BSP2 and DMP1
[11]. In this work, DMP1 and BSP2 released in the matrix was assessed by immunoflu-
orescent staining, while biochemical assays were performed to determine cell number
and ALP activity. Moreover, the expression of cell dendrites, which are characteristic of
osteocytes phenotype, were tracked by brightfield microscopy.
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The experimental tasks were developed in a professional laboratory belonging to the re-
search group Multiscale in Mechanical and Biological Engineering (M2BE) inside Arago´n
Institute of Engineering Research (I3A) at the University of Zaragoza. This project is
framed and funded within an European project Curabone (number 722535) whose global
aim is to integrate numerical simulation technologies based on image analysis in order
to enhance the customized treatments to bone fractures healing and its long term evo-
lution.
Chapter 2
Materials and methods
2.1 Fabrication of microfluidic devices
Microfluidic devices with three culture channels were fabricated following a protocol
adapted from C. Del Amo et al. (Integrative Biology, 9: 339-349, 2017) [43]. They are
made of polidimetilsiloxan (PDMS) due to its physicochemical properties.
The total procedure to manufacture each batch of devices takes 5 days. Several bunches
of devices were done in this work following the protocol explained in the following para-
graphs (summarized in figures 2.1 and 2.2).
Figure 2.1: Microfluidic devices fabrication process scheme. 1: wafer of the negative
inner geometry of the chip made by soft lithography. 2: PDMS mold of the geometry.
3: devices cut individually
Day 1 - The first day, a mold of the desired inner geometry was done. To fabricate
the mold, a wafer with the required inner geometry was needed. Those masters were
externally purchased and manufactured by lithography (figure 2.1-1).
Liquid PDMS solution was prepared by mixing Sylgard 184 silicone elastomer base
(VWR) and the curing agent in a 10:1 weight ratio (30 g silicone + 3 g curing agent per
wafer). After mixing the solution using a spatula, it was needed to degas it to remove
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air bubbles. Then, liquid silicone was poured in the wafer of the geometry and degassed
again. The last step was to cure the solution in an oven at 80◦C overnight.
Day 2 - The next day, the solidified silicone was taken out of the oven and detached from
the wafer by using a scalpel (figure 2.1-2). Then, the seven geometries were punched
with a 20 mm circular blade (figure 2.2-3) and the holes for the cells and media channels
were drilled by using disposable biopsy punches, 1 mm and 4 mm diameter respectively
(figure 2.2-4). After that, the devices had to be sterilized in two steps of autoclave.
Then, they were placed in an oven at 80◦C overnight.
Figure 2.2: 3: devices cut into individuals. 4: devices drilled with 4 mm and 1mm
biopsy punches.
Day 3 - The silicone devices were sealed to their glass covers (Ibidi Glass Bottom µ-Dish
35 mm). The covers grant a glass base to the 3D culture and make cell culture visible
under microscope. Moreover, they are shrouded, providing protection and sterility. With
this purpose, the devices and glass covers were placed in a plasma cleaner, geometry side
up. Glass covers lids were saved in a Petri dish where they are sterilized later by UV
light.
The vacuum pump and the plasma chamber were turned on to treat the surfaces of
PDMS and glass covers for two minutes. After this time, each device was bonded and
softly pressed to its glass coverslip. Now, inside a laminar flow hood, channels were filled
with 60 µl of surface coating solution Poly-D-lysine (PDL) and devices were placed in an
incubator for four hours. PDL is a synthetic molecule that improves cellular adhesion
and proteins absorption by changing superficial charges of the hydrogel. Besides, this
treatment ease the union between PDMS and the hydrogel surface.
Afterwards, PDL solution in the channels was thoroughly removed by vacuuming. Since
an excess of PDL can cause cell damage, the chamber was filled with 300 µl of sterile
deionized water using a micropipette in order to wash them. This procedure was repeated
until devices were filled with DI water from all inlets: filling and taking water out from
the opposite inlets. Then, all microfluidic channels were completely aspired. Finally,
coated devices were placed in a sterile dish at 80◦C for 48 hours.
Day 5 - Samples were taken out of the 80◦C oven. When they reach room temperature,
they can be either used or stored at up to one month.
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2.2 Cell culture loading
2.2.1 Cell expansion
Primary Human Osteoblasts (HOB, PromoCell) were cultured at 60% to 75% confluence.
These cells were isolated from donated human tissue at passage 1. As HOB growth
mode is adherent, cells were cultured and expanded in 2D inside culture flasks (T-25,
25-cm2, 7ml) forming a monolayer all over the inner surface in Dubelco’s Modified Eagle
Medium (DMEM, Gibco). DMEM expansion medium contains 10% heat-inactivated
fetal bovine serum (FBS, Lonza), 100 U/mL penicillin, and 100 µg/mL streptomycin
(Lonza). Cultures were incubated at 37◦C in a 5% CO2 atmosphere with replacement
of medium every 2-3 days.
It was necessary to take cells out of the flask in order to prepare the cell solution. The
first step was to trypsinize the cells in order to detach them from the surface. With this
purpose, old medium in the flask was removed with a Pasteur pipette (carefully from the
opposite corner of the flask neck). Then, 3 ml of Phosphate Buffered Saline (PBS) were
poured inside the flask to wash the cells to remove residual FBS that could inactivate
the trypsin. This step was repeated twice.
After that, 500 µl of trypsin (TrypLETM Express Enzyme, Invitrogen) were poured
inside the flask. Then, it was rapidly put inside the incubator at 37◦C for 1 minute.
After 1 minute, 1 ml of DMEM was added. Cell suspension (+ 500 µl of trypsin + 1 ml
of DMEM) was drawn into a tip of a P-1000 pipette and the whole solution was rinsed
two or three times to dissociate cells and to dislodge any remaining adherent cells. Then,
cell suspension was passed to a sterile 15 ml centrifuge tube.
10 µl of the cell suspension were taken to count cell concentration by using a hema-
tocytometer. In the same tube, the suspension was centrifuged for 5 minutes at 1500
rpm. The subsequent supernatant was removed and fresh DMEM was added, so all the
remainder trypsin was removed. The volume of resuspension medium depends on the
number of cells counted previously and the final cell concentration in the gel desired for
the experiment.
The determination of the number of cells in culture is important for standardizing culture
conditions and performing accurate quantification experiments. Thus, the 10 µl taken
from the previous solution were placed in the neubauer chamber (hemocytometer, figure
2.3). It is a microscopic counting grid that was used to determine the density of a cell
suspension. This tool enable to estimate the percentage of viable cells in the whole
population. It was needed to use that chamber when performing the collagen hydrogel
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in order to set the cell concentration inside the device. Once the neubauer chamber was
loaded, it was placed on the microscope and a hand-held counter was used to count cells.
cells
ml
= average count per square × 104
totalcells =
cells
ml
× total original volume of cell suspension
from which sample was taken
The volume correction factor for the tool is 104: each square is 1×1mm and the depth is 0.1mm.
Figure 2.3: Hematocytometer used to count cells: 10µl of cell suspension was poured
between the grid (red square) and a glass surface. Cells in the grid were counted and
the final concentrations was calculated by using the formula described above. Picture
adapted from supplier website: superior Marienfeld.
Cell solution after centrifugation should be five times higher than the final concentra-
tion desired in the device because it is diluted five times during the seeded hydrogel
preparation (table 2.1).
2.2.2 Collagen hydrogel preparation
A high density collagen hydrogel was prepared. The collagen final concentration was 6
mg/ml. 200 µl of gel were enough to seed up to 17 three-channel devices (figure 1.4).
Since collagen is normally stored in highly acidic solution, the gel pH must be adjusted
before adding the cell suspension. The pH of the gel was brought to 7.4 for culturing
HOB. Chemicals used to make the collagen seeded hydrogel solution are listed below:
• Collagen I, Rat Tail 8.90 mg/ml (Corning).
• 10X phosphate buffered saline (DPBS) with phenol red (Euroclone).
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• 0.5 M NaOH solution: 5 g of NaOH tablets (Sigma-Aldrich) were disolved in 230
ml of sterile deionized water by stirring. Then, this solution was sterilized using a
0.2 µm filter and, finally, the it can be stored at room temperature.
• Cell solution: during the collagen hydrogel preparation, a fixed volume of cell
solution was added independently from the final cell concentration required. This
was done to minimize errors in the loading phase due to pipetting. Table 2 shows
the volumes of the chemicals used to make 200 µl of gel.
Compound % Volume for 200 µl gel
Collagen 67,3% 134,84 µl
NaOH 0,5 M 2,7% 5,4 µl
10x DPBS 10% 20 µl
Cell solution 20% 40 µl
Table 2.1: Composition of the collagen hydrogel
Remark: those quantities were set for accurate 7.4 pH in a 200 µl gel. If
necessary, they could be modified in order to get 100 µl or 300 µl. However,
the volume of NaOH solution that achieves pH 7,4 does not follow a linear
relation, it needs to be readjusted. Figure 2.4 shows the color bar used to
rapidly identify the pH of the gel.
Figure 2.4: Color bar for collagen hydrogel pH. Volume of NaOH was adjusted until
7.4 pH was obtained
Figure 2.5: Prepared hydrogel in a 0.5 ml eppendorf vial containing osteoblasts solu-
tion and collagen type I fibers.
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2.2.3 Cell seeded gel loading
The first step was to place every compound inside a ice bucker in order to avoid early
collagen polymerization. Then, the quantities of the compounds indicated in the table
2.1 were added and gently mixed with a pipette inside a cold vial. When taking the
collagen from the aliquot it is necessary to do it slowly, waiting when the pipette gets
its limit and retract it. Then, the collagen pouring has to be gentle as well.
The procedure of preparing the collagen hydrogel and seed it into the devices must not
take more than one hour (final result in figure 2.5). The gel used during this project had
a collagen concentration of 6 mg/ml, but this value can be adapted to prepare hydrogels
with different concentrations by diluting the base solution before polymerization. Cell
final concentration used during these experiments was set to 250.000 cells/ml.
The collagen gel solution was slowly filled into the microfluidic devices through the
middle port (figure 1.4, number 1) as it is shown in the figure 2.6. It is recommended
to fill three devices at a time with 20 µl of gel suspension.
Figure 2.6: Pipetting the hydrogel inside the microfluidic device
To initiate polymerization, the gel-filled devices were quickly placed in the prepared
humid chamber with the channel side facing down. As the collagen gel polymerization
is thermally induced by heating the gel solution, the humid chamber was put in a CO2
incubator at 37◦C for 2.5 minutes.
After this time, the humid chamber was moved under the hood and the devices were
placed channel-upside. The humid chamber was placed again in a CO2 incubator for
5 minutes. this procedure was repeated 2 times (upside - downside) and, finally, the
channel side was moved face down for 2.5 minutes. The overall polymerization process
takes 20 minutes.
Remark: after the seeding inside the devices, cells will be fed with Os-
teogenic Culture Medium (OCM) to induce osteogenesis. OCM is composed
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of the expansion medium supplemented with 50 µg/mL ascorbic acid, 10 mM
βGlycerol-phosphate. The table 2.2 shows the final composition of the OCM :
Compound Composition
DMEM ≈ 89%
FBS 10%
Antibiotics 1%
L-Glutamine 2 mM
βGlycerol phosphatase 10 mM (1%)
Ascorbic acid 50 µM (0.03%)
Table 2.2: Composition of the osteogenic medium
Once polymerization was completed, OCM was added in all reservoirs of the device.
OCM was gently added through one reservoir well until the medium was observed in
the connected one. After that, all reservoirs were completely filled (200 µl each device).
The lids (sterilized by UV light) were placed covering the devices. Once hydrated with
OCM, devices were kept within a Petri dish in the incubator (37◦C and 5% CO2). The
final result of the seeding is shown in the figure 2.7.
Figure 2.7: Inner geometry of the device with the three central channels full of
hydrogel solution containing HOB hydrated with OCM
Remark: it is needed to exchange the medium every 2 - 3 days. In order to
do that, the old medium was gently vacuumed through the medium channels
(figure 1.4-2). Then, the same volume of fresh medium per device (200 µl)
was added with a pipette in one channel by dropping, letting the medium
enter into it. Inside the chamber, fresh nutrients reach the cells by diffusion
through the gel.
2.3 Biochemical assays
Two different biochemical tests were performed: Alkaline Phosphatase (ALP) produc-
tion test and DNA quantification assessment. Each timepoint of the experiment, three
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devices were studied.
2.3.1 Alkaline phosphatase production
ALP activity was determined using a colorimetric assay of enzyme activity (SIGMAFAST
p-NPP Kit, Sigma Aldrich), which uses p-nitrophenyl phosphate (pNPP) as a phos-
phatase substrate, with ALP enzyme from bovine intestinal mucosa (Sigma Aldrich) as
a standard. The substrate changes its absorbance wavelength when dephosphorylated
by ALP. The change in emission is measured at 540 nm on a plate reader (Biotek synergy
HT). Results were then normalized to cell number and the final results were expressed
in units of ALP per nanogram of genetic material.
ALP samples were taken at every timepoint of the experiment out of the culture medium
of the devices. Firstly, the devices were taken out from the incubator and, inside a
laminar flow hood, old culture medium was removed. Then, 200 µl of fresh medium per
device were poured and afterwards, devices were placed in a incubator for, exactly, two
hours. After this time, the new medium was isolated and stored in vials. This vials
are stored at −20◦C and they were the actual samples obtained from the devices. In
this way, the same volume per device (200µl) incubated the same time was obtained,
avoiding ALP denaturation that occurs in old medium.
ALP activity was measured by absorbance (protocol modified from the original proposed
by Birmingham et al. in 2012) [33]. Figure 2.8 shows a summary of the total procedure
followed, which is detailed in the following paragraphs.
Figure 2.8: Schematic sequence of the ALP activity test.
In order to measure the ALP production of the cells depending on the day of culture,
a spectrophotometry of the collected culture medium was done. To test the enzymatic
production, these samples were compared with standard quantities containing a fixed
and known quantity of the enzyme. The standard wells were determined by using known
amounts of Alkaline phosphatase from bovine intestinal mucosa (Sigma-Aldrich). Find,
in the table 2.3, the volumes to make the control standard solutions.
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Standard pNPP (µl) ddH2O (µl) OCM (µl) Final pNPP (nmol/µl)
Blank/C0 0 320 160 0
C1 4 316 160 0.03
C2 8 312 160 0.07
C3 16 304 160 0.10
C4 32 288 160 0.13
C5 48 272 160 0.17
C6 64 256 160 0.33
C7 80 240 160 0.67
Table 2.3: Composition of the standard volume to calibrate the ALP in the spec-
tophotometry
A 96-well plate was filled with the different samples that were stored with fixed quantities
of ALP as control. 40 µl of collected medium were added to the 96-well plate in triplicates
with 50 µl of pNPP solution, which contained both pNPP and assay buffer (PBS).
The standard wells were filled with 120 µl of the corresponding standard volume and
10 µl of ALP enzyme. Sample wells were filled with 50 µl of the 5 mM pNPP solution,
40 µl of the sample (obtained out of the culture medium stored) and 40 µl of deionized
water. All wells had a final volume of 130 µl (see a summary in table 2.4).
Standard well Sample Well
120 µl standard solution 50 µl 5mM pNPP solution
10 µl ALP enzyme 40 µl sample
- 40 µl deionized water
130 µl total 130 µl total
Table 2.4: Composition of standard and sample wells to perform ALP test
Then, the well plate was left 1 hour to allow the substrate and the enzyme to bind. After
one hour, the plate was placed in the spectrometer and the absorbance measurement
was performed at 405 nm in a Synergy HT Multimode microplate reader.
Solutions for ALP assay: two solutions were prepared to perform the assay described
above:
• 5 mM pNPP solution: one tablet of pNPP and one tablet of TRIS buffer were
diluted in 5 ml of deionized water (Sigma-Aldrich Kit).
• ALP enzyme solution: 1 µl of ALP enzyme (commercial 43kU/ml) was diluted in
10 ml of deionized water.
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2.3.2 DNA assessment
To quantify the DNA amount it was needed to extract the cells out of the devices. A
collagenase solution was required to degrade the collagen matrix and isolate the em-
bedded cell. The collagenase enzymatic activity was measured in collagen degradation
units per ml (CDU/ml). One CDU per ml liberates peptides from collagen equivalent in
ninhydrin color to 1.0 mmole of L-leucine in 5 hours at pH 7.4 at 37◦C in the presence
of calcium ions [44].
Regarding the results obtained in literature, the goal solution had an activity of 514
CDU/ml [45]. This solution was prepared diluting 30 mg of collagenase powder (Sigma-
Aldrich, 257 units/mg) in 15 ml of PBS. Thus, the collagenase solution final concen-
tration was 2 mg/ml obtaining 514 CDU. 15 ml of total volume were prepared and
separated in 650 µl alliquots.
After the medium collection for ALP samples, the devices were washed twice with PBS
for 5 minutes. Then, 200 µl of the collagenase solution were poured in each device (100
µl each two medium holes). Finally, devices containing collagenase solution were kept
at 37◦C on a shaker overnight while the collagen degradation was taking place.
The next day, the devices were taken out of the incubator. Inside a laminar flow hood,
the gel was gently extracted with a pipette through the middle gel channel hole. Then,
the extracted gel was poured in a vial (one vial per device). As there were remaining
cells in the bottom of the device, 200 µl of PBS were poured in the chamber and it was
washed by pipetting twice. In order to isolate all residual cells, the PBS used to wash
was also collected in the cell vials.
In order to remove the collagenase, vials (containing cells + collagenase + PBS used
for washing) were centrifuged for 5 minutes at 1500 g. Afterwards, the supernatant was
removed with a pipette and kept in other vial (wastes vial). Then, cells were resuspended
in 500 µl of PBS and centrifuged again. Finally, the supernatant was taken and kept in
the wastes vial. Cells vials were stored at −80◦C and wastes vials at −20◦C.
DNA amount at each timepoint was measured with two different procedures. The first
one follows a widely accepted method based on a fluorescence assay: Hoechst 33258 dye.
The second method uses a specific tool to measure DNA directly in a special microplate:
a complement device of Biotek Synergy spectrophotometer.
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2.3.2.1 Hoechst 33258 dyeing protocol
Solutions for Hoechst procedure: several solutions were done to perform the assay
described below:
• Hoechst dye solution: 1mg/ml Hoechst dye in deionized water. This solution is
directly provided by the supplier (Sigma-Aldrich) in the right concentration.
• 10x Hoechst buffer (HB): 6.05 g TRIZMA base (Sigma-Aldrich), 1.85 g EDTA
(Sigma-Aldrich), 29.20 g NaCl (Sigma-Aldrich) in 500 ml of deionized water. After
preparing the solution, the pH was adjusted to 7,4 using concentrated HCl, NaOH
and a pH meter.
• Working dye solution: 2 ml 10xHB and 2 µl Hoechst dye solution were diluted in
18 ml deionized water.
• DNA standard: commercial DNA salt (Sigma-Aldrich) was dissolved in 10xHB at
1mg/ml. Then, it was diluted 50 times in sterile deionized water (to 20 µg/ml).
An adapted protocol for Hoechst 33258 widely used was followed [46]. This technique
consist on dying DNA with the Hoechst solution and quantify it by fluorescence. The
quantification was done by comparing the fluorescence obtained with results from stan-
dards; which were made of Deoxyribonucleic acid sodium salt from calf thymus.
The procedure began by thawing the frozen samples of isolated cells. Then, 250 µl of a
tampon solution of 10XHB per sample (detailed above). This buffer stabilizes the DNA,
so the whole test was performed using this buffer as solvent.
After that, the sample must undergo to at least 2 freezing and thawing cycles. This
procedure induces breakage of cell membranes and DNA release in the solution. Samples
may be stored temporarily at the third thaw. However, it is better to thaw the samples
and carry out the Hoechst assay while transferring the remaining sample to 0.5-1 ml
tubes for storage at −80◦C.
In order to quantify the amount of DNA in the samples, standards were prepared. See
table 2.5 the volume used for this preparation.
Afterwards, the working dye solution was prepared in minimal light conditions (compo-
sition detailed above). Once this solution was prepared, 20 µl of each standard/ sample
saolution were added into individual wells (triplicates). Finally, in minimal light condi-
tions, 200 µl of the working dye solution were added to each well using multi-channel
pipette. Table 2.6 shows the composition of both sample and standard wells.
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Standard DNA/well [ng] 4X scale mix DNA standard (µl) 1XHB 80µl
Blank/C0 0 0 0 80
C1 15 60 3 77
C2 30 120 6 74
C3 45 180 9 71
C4 75 300 15 65
C5 150 600 30 50
C6 225 900 45 35
C7 300 1200 60 20
Table 2.5: Composition of the standard volume to calibrate the DNA content
Standard well Sample Well
20 µl standard solution 20 µl sample solution
200 µl working dye solution 200 µl working dye solution
220 µl total 220 µl total
Table 2.6: Composition of standard and sample wells to perform Hoechst DNA assay
The plate was placed in the spectophotometer on fluorescence mode and emission and
excitation were measured at 485 nm and 380 nm respectively.
2.3.2.2 Microvolumes Plate (TAKE3) DNA quantification
The second technique used to quantify DNA content in the microfluidic devices was:
Multi-Volume Analysis of Nucleic Acids Using the EpochTM Spectrophotometer System
(Biotek, Synergy HT). This tool allows to measure nanograms of DNA per µl in a single
3 µl drop of the sample solution. See in the figure 2.9, a picture of the DNA reader tool
and the spectrophotometer.
Figure 2.9: A: dropping DNA solutions in the microplates. B: tool filled and ready
to run the measurement. C: spectrophotometer Biotek Synergy HT.
Having the samples frozen at −80◦C, it was needed to do the freezing-thawing cycles to
lyse the membrane the same way as explained in the Hoechst procedure.
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Previous to the placement of the samples in the the microvolume plate, it was washed
with PBS and ethanol 70%. Then, 3 µl of PBS were dropped in each micro well to make
a first measure as a blank control.
Afterwards, 3 µl of each sample were taken and dropped in the plate as shown in the
figure 2.9 (A). Finally, the TAKE3 program of the spectrophotometer software was used
to read DNA content.
DNA content measure consists of a direct quantification of nucleic acids using the spec-
trophotometric absorbance at 260 nm. This fact is possible due to the subnanometric
structure composition of genetic material [47].
2.4 Cell dendrite tracking
Brightfield microscope (Nikon D-Eclipse C1 Confocal Microscope) was used to track cell
dendrites in real-time, while cell culture is taking place. In order to track cell dendrites,
several pictures in Z-Stack mode were taken to watch cells in 3D. The Z-Stack consists in
taking pictures of a region increasing the step through a sample. Brightfield microscopy
was done every 4 - 5 days during the entire duration of the experimentation phase.
As a future task inside this project, a tracking software will be developed where, ana-
lyzing the Z-Stack pictures, the user will be able to extract: the geometry of the cell
dendrites, the number of dendrites and the connections between them.
2.5 Fluorescent staining
Cell morphology, Calcium deposition and proteins release were determined by confocal
microscopy. The microscope used was Zeis LSM880 confocal microscope.
Several stains were used to dye the samples in order to differentiate the components of
the cell and specific proteins inside the cytoplasm as well as compounds released in the
matrix (table 2.7):
• DAPI (Invitrogen): it is a fluorescence stain that binds strongly to DNA so it allows
the user to watch the cell nuclei in a fluorescence microscope. The excitation and
emission wavelengths are 340 and 454 nm respectively.
• Phalloidin TRIC, Tetramethylrhodamine B isothiocyanate, (Sigma-Aldrich): it is
a fluorescence stain that binds actin filaments so that makes it possible to observe
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part of the cytoskeleton as well as distinguish cell contour. The excitation and
emission wavelengths are 540 and 570 nm respectively.
• Calcein (Sigma-Aldrich): it is a non toxic fluorescence stain that binds the Calcium
so it allows the user to watch the calcium deposition in the extracellular matrix.
The excitation and emission wavelengths are 470 and 509 nm respectively.
Apart from those, which are used to perform a regular staining, two primary antibodies
and two fluorescent secondary antibodies were used to make an immunostaining. This
approach consists of using a couple of antibodies to bind targeted biomolecules. Firstly,
the primary one binds selectively to the target. Then, the secondary antibody, which is
the fluorescent one acting like a label, binds to the primary. When exciting the sample
with excitation wavelength of the secondary antibody, its emission is detected if the
sample contains the targeted biomolecule.
The antibodies used are provided by Santa Cruz Biotechnology supplier:
• Primary antibody:
– Mouse monoclonal Anti-BSP2. As commented in Chapter 1, BSP2 is a pro-
tein typical in cell expression of mature osteoblasts phenotype.
– Mouse monoclonal Anti-DMP1. As commented in Chapter 1, DMP1 is a
protein that indicates the osteoblasts-osteocytes transition.
• Secondary antibody (Alexa fluor compounds):
– Mouse IgGGKappa secondary CruzFluor 594 (table 2.7).
– Mouse IgGGKappa secondary CruzFluor 680 (table 2.7).
Compound Emission Excitation
DAPI 454-488 nm 340-364 nm
Phalloidin 570-573 nm 540-545 nm
Calcein 509 nm 470 nm
IgG 594 614 nm 594 nm
IgG 680 701 nm 680 nm
Table 2.7: Emission and excitation wavelengths of the fluorescence compounds used
DAPI, Phalloidin and antibodies solutions were supplied directly in the appropriate
stain concentration. However, Calcein was bought in powder, so it needed to be diluted
before use.
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To prepare the Calcein solution at the concentration of 2.5 mg/ml (the one used in
bibliography [30]), 5 mg of Calcein powder were dissolved in 2 ml 0.5 M NaOH solution.
After homogenizing, the solution was sterilized with a 0.2µm nylon filter, wrapped with
aluminum foil and stored at 4◦C. To stain calcium deposited, Calcein solution was
provided to the cells together with OCM in a proportion of 100:1 (100 µl of medium +
1µl solution Calcein-NaOH).
Remark: starting from this point, it is important to work in minimal light
conditions in order to avoid fotobleaching in the sample.
Unlike Calcein, which stains calcium deposition while the cells are alive, staining with
DAPI, Phalloidin and antibodies involves a procedure of two days. Classical fluorescent
staining of biological samples takes less time. In this case, stains need to diffuse in
a 3D matrix with high collagen concentration, so it takes longer times to reach the
target compounds. The protocol for staining the samples is detailed in the following
paragraphs.
Day 1: The devices were taken out of the incubator and their OCM was removed by
aspiring gently with a pipette. Then, they were cleaned with PBS twice for 5 minutes.
The next step is to fix the sample by using paraformaldehyde (PFA). In order to do
that, 200 µl of PFA in a solution of 4% in PBS (Affymetrix) were poured in each device
and left for 30 minutes. This step should be done inside a fume hood due to the toxicity
of the PFA.
While PAF was fixing living tissue, two solutions for the following steps were prepared:
• 0.1% Triton X-100 solution in PBS (Calbiochem). 1 µl of Triton X-100 was diluted
in 1 ml of PBS. Triton solution is commonly used to permeabilize cell membrane
and allow the fluorescent reagents to get the cell body and stain the target com-
pounds.
• 5% Bovine Serum Albumin (BSA, VWR): solution of 5 w/v in PBS which corre-
sponds to 12.5 mg in 250 µl (each device). This solution was filtered by using a 0.2
µm filter. BSA solution is a widely used blocking agent that prevents non specific
bindings of the fluorescent stains.
After the 30 minutes, PFA was removed with a pipette. Then, the samples were washed
three times with PBS. After 3 washing steps, 200 µl of the solution of Triton X-100 per
device were poured. Then, they were left for 30 minutes on a shaker to enhance the
processes of diffusion. After that time, the Triton solution was removed with a pipette.
The last step was to pour 200 µl of the BSA 5% solution in each device. Finally, devices
were placed on the shaker at 4◦C overnight.
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Day 2: A solution of BSA 0.5 % in PBS was prepared by diluting the former 5% BSA
solution made in day 1 in a total volume of 200 µl per sample: 20 µl of the solution of
5% BSA in PBS and 180 µl of fresh PBS.
At this point, the primary antibody was supplied to the cells. 10 µl of antibody solution
(directly provided in the commercial vial) were diluted in 0,5 ml of 0,5% BSA solution.
Then, 200 µl of this solution were poured in each device and they are kept for, at least,
6 hours at 4◦C on a shaker.
As two targets are studied (BSP2 and DMP1), two solutions were prepared; each one
with the corresponding antibody. This way, there were some samples with stained BSP2
and others with stained DMP1.
After the 6 hours, other three steps of washing with PBS were required. Then, secondary
antibody, DAPI and phalloidin were given to the culture. The dyeing solution was made
in the 0.5% BSA:
• DAPI (1:50): 8 µl of DAPI were diluted in 400 µl of 0.5% BSA solution.
• Phalloidin (1:10): 40 µl were diluted in the same 400 µl of 0.5% BSA solution.
• Secondary antibody (1:50): 8 µl of antibody solution were diluted in the same 400
µl of 0.5% BSA solution.
200 µl of the dyeing solution were poured in each device. Finally, stained samples were
kept on the shaker into the fridge overnight (4◦C) wrapped with aluminum foil.
Day 3: In order to get the sample ready to use, the samples were taken out of the fridge
and the liquid from the medium channels was gently removed with a pipette. Then,
samples were washed again with PBS. At this point, it was possible either to watch the
samples in a fluorescence/confocal microscope or store them in PBS at 4◦C.
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Results
3.1 Alkaline phosphatase production tests
3.1.1 Collagen hydrogel extraction
Collagen hydrogel was extracted from the devices and DNA content of the embeded
cells was measured to normalize ALP activity. The gel extraction protocol (detailed in
2.3.2) became a new and innovative technique to isolate cells from the matrix after the
culture. The picture below shows the inside of a microfluidic device with three channels
before and after the extraction of the collagen hydrogel.
Figure 3.1: Brightfield microscope picture (magnified at 2X) of the culture chamber of
a microfluidic device before and after the extraction of the gel; left and right respectively.
After the extraction, there were not remaining cells inside the chamber but just some
rests of PBS around the channels.
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3.1.2 ALP activity
It was possible to quantify the ALP activity in the samples following the protocol ex-
plained in 2.3.1. The plot below shows the ALP activity before normalizing it (according
DNA content) expressed in terms of mili-units (mU) per ml. One unit (U) hydrolyzes
1.0 µmol of pNPP to p-nitrophenol and inorganic phosphate in one hour per minute (at
pH 9.8 and at 37◦C).
Figure 3.2: ALP activity in mU/ml of the HOB at days 3, 7, 14 and 21. Samples
were obtained from the 2 hours OCM.
ALP activity was approximately constant over time so there was not a clear decrease
in the enzyme activity. Despite that, his value should be normalized to determine if
cells were differentiating. In this way, the amount of ALP produced per cell can be
calculated.
3.1.3 DNA quantification
The first task was to check the repetitiveness and reliability of both techniques detailed in
2.3.2: Hoechst assay and microvolumes plate. Standards prepared in Hoechst procedure
were used to evaluate the outputs of two different techniques.
Standards with lower amount of DNA did not show presence of DNA with both tech-
niques, while comparable values of DNA were observed for standards with higher DNA
content. This fact was associated to the standard solution preparation process, due to
the small volume of DNA solution added (order of 1µl). This technical problem made
microvolume plate technique more reliable, because it does not need the use of any
standard to quantify the DNA concentration in our solution.
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Figure 3.3 shows the amount of DNA in the tested samples. Looking at these values,
DNA content did not increase significantly over time. Thus, assuming that every mi-
crodevice contained approximately the same amount of cells in the beginning, it could
be assured that cells did not proliferate in the gel.
Figure 3.3: DNA content in ng of the microfluidic devices at days 3, 7, 14 and
21. The samples were obtained out of the extracted hydrogel and measured with the
microvolumes plate.
Values in units of ng DNA/µl were provided by the microvolumes plate TAKE3 software.
Multiplying this amount by the volume of DNA solution, gives the DNA amount in each
sample (figure 3.3). The volume of solution in each sample was not the same because
of the variability of the supernatant removed after centrifugation. Volumes of DNA
solution in the samples were measured by pipetting.
The highest value of DNA content was seen in the first timepoint. Then, there was
a decrease in the genetic material content that kept roughly constant. Assuming that
every device contained the same number of cells in the beginning, it can be confirmed
that there was not osteoblasts proliferation.
3.1.4 ALP normalization
Normalized ALP activity was obtained by the ratio of the results of the two previous
sections (figure 3.4).
The lowest value of ALP activity was present in the first timepoint. Then, at day 7
there was an increase of 24%. After this, normalized ALP activity seemed to have a
decreasing trend (approximately 6% from day 7 to day 21). Watching this tendency, it
is expected that, the decrease is more pronounced if setting longer timepoints.
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Figure 3.4: Normalized ALP activity boxplot according DNA content in the samples
at days 3, 7, 14 and 21.
The reduction showed in the plot showed in figure 3.4 was not statistically meaningful.
Thus, osteogenic differentiation was not arising after 21 days of culture, seeding 250.000
cells/ml inside the chamber.
3.2 Cell dendrite tracking
One of the main results immediately observed during culture was the difference in cell
shapes if they were adhering to the bottom of the device (2D culture) or if they were in
the middle of the gel (3D culture). As it can be observed in the figure 3.5, when cells
are lied down on the glass (left), they are bigger than those cultured inside the matrix in
3D (right). Moreover, their dendrites are more numerous and longer. These differences
can be explained by the cellular mechanobiology and the principles of cell migration in
two and three dimensions [48].
Each time of tracking, more dendritic cells were found. This means that cell dendrites
number increased with time (figure 3.6). Besides, it can be asserted that dendrites get
longer, while cell body gets smaller. This tendency matched with the expected behaviour
explained in the introduction chapter.
Apart from the presence of dendrites, several cell-cell connections were tracked and
found, emerging in the longest timepoints (figure 3.7). However, those were not compa-
rable to the ones observed in a osteocytic network.
Results obtaining in DNA quantification were double checked in cell tracking: there was
not a clear increase in cell content along time (figure 3.8). This fact means that there
was not cell proliferation. Providing that, cell number at day 21 was similar to cell
number in the beginning of the test.
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Figure 3.5: Brightfield microscope pictures magnified at 10X of 2D cells and 3D cells
(left and right respectively) inside a microfluidic device after 21 days of culture.
Figure 3.6: Two slides of a brightfield microscope Z-Stack of a mature and dendritic
osteoblast, magnified at 20X
Brightfield microscope pictures can be processed in a software developed in the research
group created by Python: ImagePy. Over this work, ImagePy was utilized in user mode
to support dendrite tracking.
The program allows the user to select a region to study and to highlight the dendrites
(figure 3.9). Up to now, cell contour is defined manually. However, in a future, cell
contour detection will be automatic.
Then, the program is able to distinguish the cell body and the dendrites. It also calcu-
lates the length of the dendrites, counts the number of them and the possible connections
between cells thanks to powerful image processing tools (figure 3.10).
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Figure 3.7: Brightfield microscope images of cells connection magnified at 20X
Figure 3.8: Brightfield microscope pictures magnified at 2X of the culture chamber
at days 1 (left) and 21 (right) of culture
3.3 Osteoblasts mineralization and differentiation
Osteoblasts mineralization was assessed by calcium deposition in the matrix and the
expression of protein BSP2. On the other side, osteogenic differentiation would result
in expression if protein DMP1. Proteins mentioned above were tracked with proper
antibodies and observed in a confocal microscope thanks to the staining detailed in
section 2.5.
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Figure 3.9: Interface of the program developed by Python (ImagePy). The software
is able to open pictures and Z-stack in a microscope format and manually select the
cell to study
Figure 3.10: Analyzed cell by the software ImagePy. It is possible to distinguish the
cell contour (blue), cell body (red), primary dendrites (yellow) and secondary dendrites
(white). The program offers a summary of the cell information (right)
Four samples were used to stain cells and proteins. The samples were incubated up to
28 days, they were stained with Calcein for five days and, finally, fixed. Then, two of
them were stained with anti-BSP2 and the other two with anti-DMP1. Finally, every
sample got DAPI to bind the cell nuclei.
Figure 3.11 was taken from a sample stained with anti-BSP2, Calcein and DAPI after
28 days of culture. It shows an osteoblast in a mature differentiation phase, which has
a considerable amount of calcium released into the matrix, as well as a high expression
of BSP2.
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Figure 3.11: Confocal microscopy picture of a tridimensional osteoblast magnified at
40X. Cell nuclei has been stained with DAPI (blue), calcium deposition of the matrix
and cytoplasm is stained by Calcein (green) and BSP2 protein is stained by immunos-
taining with an AlexaFluor reagent (red)
In contrast, DMP1 staining did not show a significant amount of this protein. Figure
3.12 was taken from a sample stained with anti-DMP1, Calcein and DAPI after 28 days
of culture.
Figure 3.12: Confocal microscopy pictures of two tridimensional osteoblasts magni-
fied at 40X. Cell nuclei has been stained with DAPI (blue), calcium deposition of the
matrix and cytoplasm is stained by Calcein (green) and DMP1 protein is stained by
immunostaining with an AlexaFluor reagent (red)
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Discussion
The main goal of this work was to study the feasibility of creating in vitro bone models
in the microfluidic devices. Apart from that, this work also aimed to achieve long-term
culture of bone cells all over the 3D culture environment. In all these experiments, cul-
ture conditions were used to induce matrix mineralization and osteogenic differentiation,
with a final target to develop a fully differentiated osteocytic phenotype.
Techniques used here demonstrated the possibility of using microfluidics and collagen
hydrogel matrix to recreate a tridimensional bone model in vitro after culturing primary
human osteoblasts for 21 days. Thus, the two first targets of the work were achieved.
Osteoblasts mineralization and differentiation processes were studied by quantifying
ALP enzyme activity, tracking calcium deposition and monitoring specific proteins re-
lease.
There was not a clear decrease in the ALP activity over time, contrary to what was
expected. Nevertheless, Calcium deposition was observed. Regarding these results,
some conclusion can be observed: firstly, as there was not a significant reduction of ALP
activity over time, osteogenic differentiation was not taking place. Secondly, despite this
first result, osteogenic behaviour was achieved because of the presence of the enzyme.
Besides, Calcium deposition suggests that osteoblasts mineralization was arising; which
also supports the latest assertion.
Those statement were corroborated by the proteins expression tracking. The presence of
BSP2 in the matrix confirmed that HOB showed osteogenic behaviour after the culture.
On the other side, the absence of DMP1 expression supported the lack of osteocytic
differentiation.
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ALP quantification protocol succeeded in the correct measurement of the enzyme but
there were complications when normalizing activity. The comparison of the two ex-
plained techniques to quantify DNA was no possible. Owing to the limited amount of
DNA, making triplicates for the Hoechst assay would have led to an excessive dilution
of the DNA, confirming that the microvolume plate was the best technique to measure
DNA in this case. To solve this trouble, new standard of higher values can be set.
The deficient proliferation of the osteoblasts in the 3D culture involved an underpopula-
tion in the chamber after seeding a density of 250.000 cells/ml. These results and some
differences between this work and others on literature suggest that the low cell concen-
tration inside the device limited osteocytic cell transition [13, 20]. This fact means that,
the formation of an osteocytic network could be achieved by increasing the cell density
in the hydrogel. In this way, the culture could behave similar to bone tissue.
However, a great number of cells in the chamber might compromise the stability of the
gel over time. In the figure 3.8-right it can be appreciated a detachment of the gel in the
upper corners of the culture chamber. The detachment was caused by the strength of
primary osteoblasts when they were migrating. Increasing cell population, this effect is
enhanced, so the gel could detach in earlier timepoints. If this problem arises in future
tasks, there would be suitable solutions to test. The fastest solution would be to use
the protein transglutaminase to fabricate the gel, doing it more resistant to contraction.
The second solution, more time consuming but more realistic, would be to seed a high
population just in the centre channel of the chamber and, the other two channels would
be filled with no-cells hydrogel. In this way, the strength of the culture would not be
enough to detach the gel from the posts.
Microfluidic devices demonstrated that they are a powerful tool to study osteoblasts
behaviour. Despite many authors have used microfluidics platforms before to study
bone cells behaviour [11], this work has been able to create a new 3D bone model in
vitro. The procedures that have been explained in this document, proved themselves to
be a robust tool to assess cell population behavior inside the microdevices in in vitro
experiments.
However, the expected results were not totally achieved. Some of the limitations of the
techniques developed in this work are:
• DNA isolation procedure must be optimized yet. The parameters for centrifuging
were modified from the original protocol.
• New control standards should be defined to double check the reliability of micro-
volume plate. Provided Hoechst assay cannot be performed with the available
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equipment, other techniques are suggested on literature, for instance: PicoGreen
DNA kit [37].
• The cell density used (250.000 cells/ml) was chosen after some results observed in
literature [20]. However, this optimized population did not seem to be enough for
the purposes of this work. Mullen et al studied mouse bone cell line (MC3T3);
which are genetically modified to proliferate more. At the end of their study,
the number of present cells were significantly higher [20]. Nevertheless, primary
human osteoblasts do not proliferate in 3D as fast as the MC3T3 do (figure 3.8).
• It was not possible to dye cells with both antibodies anti-DMP1 and -BSP2 to-
gether with phalloidin due to the proximity of the emission and excitation wave-
lenght between them. Unless phalloidin is used, cell shape cannot be well known.
Changing the Alexa fluor reagents to immunostain samples, it can be possible to
stain a single device to target the two proteins and the cell actin filaments.
Regarding the results obtained in this work, and the limitations mentioned above, next
experiments might follow different leads:
• Repeating the experiment with higher cell density and longer timepoints. It is
expected that, by increasing the number of cells in the devices, connections arise
earlier and in higher numbers. Obtaining this osteocytic network would be the
last step of the osteogenic differentiation. This test will be repeated assaying more
number of samples in order to run reliable statistics.
• Purchase new primary and secondary antibodies to stain one single device with
anti-DMP1 and -BSP2 together with phalloidin. The reagents suggested are the
Alexa fluor 555 and Alexa fluor 633.
• As cell might have autofluorescence, negative control microfluidic devices will be
imaged to compare emission intensities and delete the backgound noise from the
confocal images.
• Study other markers of osteoblast-osteocyte differentiation. For instance, expres-
sion of E11 antigen; a membrane protein more present in transitional cells and
in final osteocytes, as well as others extracellular matrix proteins: osteocalcin,
osteonectin, fibrinectin, etc [10, 11, 13].
If the desired results are obtained by implementing the new suggestions, many different
lines could take advantage of this work. One of the ideas of the long term works is to
perform a similar study but seeding cells coming from patients suffering from osteoporo-
sis. By doing this, behaviour of both types would be compared and some conclusions
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about the disease could be reached. For instance, it could be possible to find a stimuli
to reduce the overcome limitations of osteoporosis.
Another related field of study may involve scaffold-like biomaterials (titanium or degrad-
able polymers) inside the hydrogel. The purpose would be to study the interactions and
the cell growth around the biomaterial surface, to get some conclusions about a possible
improvement of current bone scaffolds.
Finally, all this result could be extrapolated to the macro-scale, which involves the use of
a tool that provides the macro-culture with physiological conditions: mechanical forces
and fluid flow. This machine is called bioreactor and it is also a trend field of research
in biomedical engineering. In this way, in vitro studies on the real scale bone scaffold
could be performed.
Most of the recent knowledge on the phenotype and functions of bone cells has been
obtained using mouse cells [7, 8, 13, 20, 36, 49, 50]. Mouse cell lines (for instance,
MC3T3) are genetically modified bone cells whose behaviour includes a excessive pro-
liferation. They get expressed the same gene of cancer cells, so their original phenotype
is inexorably compromised.
Even though the use of mouse cells is widely extended, conclusions cannot be totally
extended to human cells. Studies in human cells are limited by their price. However,
they can be affordable by using microfluidics.
While most of in vitro bone models are developed in 2D, the culture done here is tridi-
mensional. Microfluidic platforms showed in this work provides a tool for performing
3D cultures of human cells in a highly tunable environment
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ALP test was selected from the literature [13, 20] due to its role in osteoblasts activ-
ity. The procedure followed was adapted from the literature regarding the available
equipment on the M2BE labotatory. The protocol presented in this work succeeded in
measuring the ALP activity.
DNA content of the samples could not be measured by using the Hoechst 33258 dye assay.
Although this technique was selected from the literature because it is widely used, several
problems arose regarding the standard curve to determine the DNA content. Thus, the
amount of DNA was measured thanks to a different tool to quantify nuclei acid called
as Microvolumes plate.
ALP test demonstrated that osteogenic behaviour was expressed in osteoblasts when
they are seeded in the tested conditions. The expression of a mature osteoblastic pheno-
type was supported by the presence of BMP2 protein. However, the lack of a reduction in
ALP activity over time, suggested that no osteoblast-osteocyte differentiation occurred.
This issue was also suggested by the lack of DMP1 protein expression in the matrix.
Regarding cell shape, it was achieved a osteocyte shape after some days of culture.
Dendrites joined to each other and cells tended to reshape and become a net-shaped
structure. However, as there was not cell proliferation, the population inside the hydrogel
was lower than expected. Thus, these groups of connected cells were composed of 2, 3
or, maximum, 4 cells.
These techniques are potential methods for reproducing bone tissue-like in vitro mod-
els. Cells were cultured in a 3D matrix and they end up connected to each other after
a long-term culture. Besides, after providing them with the adequate culture condi-
tions, Calcium deposition proved that matrix gets mineralized and the culture showed
osteogenic behaviour.
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However, a full osteogenic differentiation was not achieved. The negative results obtained
here, suggest that a possible solution to get the total osteoblast-osteocyte differentiation
is to seed devices with higher cell density and, if possible, extend the timepoints of the
experiments.
Appendix A
List of chemicals
Table A.1 shows a list of all chemical reagents used along this work; together with the
supplier company and the catalog number of the product.
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Compound Supplier Catalog number
10X DPBS Sigma-Aldrich D1408-500ML
β-Glyerol phosphatase Sigma-Aldrich 50020-100G
ALP solution Sigma-Aldrich P6774-1KU
Ascorbic acid Sigma-Aldrich A8960-5G
BSA VWR 97061-416
Calcein Sigma-Aldrich C0875-5G
Collagen Type I, Rat Tail Corning 354249
Collagenase powder Sigma-Aldrich C0130-100MG
DAPI Invitrogen D1306
DNA standard Sigma-Aldrich D3664-5X1MG
DMEM (low glucose) Invitrogen 31885-023
EDTA Sigma-Aldrich EDS-500G
FBS Lonza 14-471 F
Glutamine (L-Glutamine) Lonza 17-605E
Hoechst 33258 dye solution Sigma-Aldrich 94403-1ML
Human osteoblasts (primary HOB) PromoCell C-12720
Mouse IgG secondary 594 nm Santa Cruz SC-516178
Mouse IgG secondary 680 nm Santa Cruz SC-516180
Mouse monoclonal anti BSPII Santa Cruz SC-73630
Mouse monoclonal anti DMPI Santa Cruz SC-73633
PBS Lonza BE17-516F
PDL Sigma-Aldrich P7886-100MG
Penicillin-Streptomycin-Amphotericin B Lonza 17-745 E
PFA (solution 4% in PBS) Affimetrix 19943
Phalloidin Sigma-Aldrich P1951-.1MG
SIGMAFAST pNPP kit Sigma-Aldrich N1891-5SET
Sodium Chloride (NaCl) Sigma-Aldrich S5886-1KG
Sodium hydroxide (NaOH) Sigma-Aldrich 655104-500G
Sylgard 184 (PDMS) VWR 634165S
TBS Sigma-Aldrich T5912-1L
Trypsin (TrypLE&trade) Invitrogen 12605010
Triton X-100 Calbiochem 648466
Table A.1: List of chemical reagents, suppliers and catalog numbers
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